MONTREAL, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TH:CA) (NASDAQ: THTX), a biopharmaceutical company focused on development and commercialization of innovative therapies, today ...
Week one outcomes of rezafungin vs caspofungin treatment for candidemia and invasive candidiasis (CIC): pooled analysis of two randomized trials exploring optimal echinocandin duration ...
Shionogi Inc., a United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will share17 scientific presentations from across its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback